Next, we examined whether an increase in hepatic Smpd3 expression could result in an increase in circulating ceramides and thereby contribute to the increased development of atherosclerosis with FEN treatment in LDLR−/− mice. The gene discussed is SMPD3; the disease is atherosclerosis.